Education
About Us
Working with TipRanks
Follow Us
Jade Biosciences (JBIO)
NASDAQ:JBIO
Total Valuation
Jade Biosciences has a market cap or net worth of $258.40M. The enterprise value is $63.88M.
Market Cap$258.40M
Enterprise Value$63.88M
Share Statistics
Jade Biosciences has 32,626,730 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding32,626,730
Owned by Insiders4.08%
Owned by Institutions64.41%
Financial Efficiency
Jade Biosciences’s return on equity (ROE) is 2.01 and return on invested capital (ROIC) is -116.90%.
Return on Equity (ROE)2.01
Return on Assets (ROA)-1.29
Return on Invested Capital (ROIC)-116.90%
Return on Capital Employed (ROCE)-1.17
Revenue Per Employee0.00
Profits Per Employee-1.88K
Employee Count50
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Jade Biosciences is ―. Jade Biosciences’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value-9.91
Price to FCF―
Price to Operating Cash Flow-3.13
PEG Ratio―
Income Statement
In the last 12 months, Jade Biosciences had revenue of 0.00 and earned -93.96K in profits. Earnings per share was -18.79.
Revenue0.00
Gross Profit-282.00K
Operating Income-71.08K
Pretax Income-93.96K
Net Income-93.96K
EBITDA0.00
Earnings Per Share (EPS)-18.79
Cash Flow
In the last 12 months, operating cash flow was -54.38M and capital expenditures -136.00K, giving a free cash flow of -54.52M billion.
Operating Cash Flow-54.38M
Free Cash Flow-54.52M
Free Cash Flow per Share-1.67
Dividends & Yields
Jade Biosciences pays an annual dividend of $2.4, resulting in a dividend yield of 29.56%
Dividend Per Share$2.4
Dividend Yield29.56%
Payout Ratio-17.51%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.43
52-Week Price Change6.84%
50-Day Moving Average7.74
200-Day Moving Average8.77
Relative Strength Index (RSI)55.64
Average Volume (3m)86.75K
Important Dates
Jade Biosciences upcoming earnings date is Nov 17, 2025, Before Open (Confirmed).
Last Earnings DateAug 13, 2025
Next Earnings DateNov 17, 2025
Ex-Dividend DateApr 29, 2025
Financial Position
Jade Biosciences as a current ratio of 5.81, with Debt / Equity ratio of 0.39%
Current Ratio5.81
Quick Ratio5.81
Debt to Market Cap0.23
Net Debt to EBITDA0.00
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Jade Biosciences has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Jade Biosciences EV to EBITDA ratio is 0.00, with an EV/FCF ratio of 733.61.
EV to Sales0.00
EV to EBITDA0.00
EV to Free Cash Flow733.61
EV to Operating Cash Flow733.61
Balance Sheet
Jade Biosciences has $220.94M in cash and marketable securities with $792.00K in debt, giving a net cash position of $220.15M billion.
Cash & Marketable Securities$220.94M
Total Debt$792.00K
Net Cash$220.15M
Net Cash Per Share$6.75
Tangible Book Value Per Share-$9.36
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Jade Biosciences is $17.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$17.00
Price Target Upside109.36% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast―
EPS Growth Forecast72.33%